XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]        
Net loss $ (18,697) $ (11,552) $ (37,419) $ (23,360)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 800 300 1,221 512
Amortization of operating lease right-of-use assets     919 1,433
Accretion of discount on short-term investments     (952) 0
Gain on extinguishment of convertible notes 0 (1,289) 0 (1,289)
Change in fair value of contingent earnout liability (148) (8,878) (207) (8,878)
Stock-based compensation expense     7,197 9,886
Other non-cash charges     (5) 21
Changes in assets and liabilities:        
Accounts receivable     64 (90)
Prepaid expenses and other assets     0 (1,372)
Accounts payable     885 234
Accrued expenses and other current liabilities     (2,082) 203
Deferred revenue     (635) (999)
Operating lease liabilities     1,035 7,945
Net cash from operating activities     (29,979) (15,754)
Cash flows from investing activities        
Purchases of short-term investments     (17,990) 0
Maturities of short-term investments     37,000 0
Purchases of property and equipment     (10,176) (18,640)
Net cash from investing activities     8,834 (18,640)
Cash flows from financing activities        
Proceeds from Merger and related PIPE financing, net of transaction costs     0 112,464
Proceeds from issuance of common stock upon exercise of stock options     0 521
Proceeds from issuance of common stock under Employee Stock Purchase Plan (ESPP)     308 0
Proceeds from issuance of convertible notes     0 5,175
Principal finance lease payments     (62) 0
Net cash from financing activities     246 118,160
Net decrease in cash and cash equivalents     (20,899) 83,766
Cash, cash equivalents, and restricted cash, beginning of period     60,987 59,291
Cash, cash equivalents, and restricted cash, end of period 40,088 143,057 40,088 143,057
Reconciliation of cash, cash equivalents and restricted cash        
Cash and cash equivalents 36,752 139,800 36,752 139,800
Restricted cash 3,336 3,257 3,336 3,257
Total cash, cash equivalents and restricted cash $ 40,088 $ 143,057 40,088 143,057
Supplemental disclosures of noncash financing and investing items        
Purchases of property and equipment in accounts payable and accrued expenses     1,796 9,371
Merger and related PIPE financing costs included in accounts payable and accrued expenses     $ 0 $ 263